Zorifertinib With Osimertinib for NSCLC With Meningeal Progression

Clinical trial NCT07361705 · RECRUITING

Trial details

NCT number: NCT07361705
Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment

Start date: 2026-01-31
Primary completion: 2028-04-23
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.